Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$1,494 Mln
Revenue (TTM)
$4,253 Mln
Net Profit (TTM)
$-1,425 Mln
ROE
-0.4 %
ROCE
-19.2 %
P/E Ratio
--
P/B Ratio
0.5
Industry P/E
--
EV/EBITDA
8.4
Div. Yield
10.6 %
Debt to Equity
1.4
Book Value
$21.2
EPS
$-10.3
Face value
--
Shares outstanding
137,649,352
CFO
$5,731.70 Mln
EBITDA
$15,121.80 Mln
Net Profit
$-3,720.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Perrigo Company PLC (PRGO)
| -22.1 | -17.9 | -22.1 | -60.8 | -32.9 | -23.2 | -21.8 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Perrigo Company PLC (PRGO)
| -45.9 | -5.6 | -12.4 | -13.0 | -13.4 | 33.3 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper... respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Read more
President, CEO & Director
Mr. Patrick Lockwood-Taylor
Chief Transformation Officer and Executive VP of Global Operations & Supply Chain
Mr. Ronald C. Janish
Headquarters
Dublin
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Perrigo Company PLC (PRGO) is $10.85 (NYSE) as of 02-Apr-2026 16:00 EDT. Perrigo Company PLC (PRGO) has given a return of -32.87% in the last 3 years.
Since, TTM earnings of Perrigo Company PLC (PRGO) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.35
|
0.66
|
|
2024
|
-20.59
|
0.82
|
|
2023
|
-343.34
|
0.91
|
|
2022
|
-32.66
|
0.95
|
|
2021
|
-75.43
|
1.01
|
The 52-week high and low of Perrigo Company PLC (PRGO) are Rs 28.44 and Rs 9.23 as of 04-Apr-2026.
Perrigo Company PLC (PRGO) has a market capitalisation of $ 1,494 Mln as on 02-Apr-2026. As per SEBI classification, it is a company.
Before investing in Perrigo Company PLC (PRGO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.15
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.